Skip to main content

Table 5 Analysis of OGTT from baseline to 12 weeks (PP)

From: A clinical trial on anti-diabetic efficacy of submerged culture medium of Ceriporia lacerata mycelium

  

Placebo

CLM

p valuea

p valueb

 

Mean ± SD

Blood glucose

Baseline

147.4 ± 48.4

148.3 ± 56.6

0.945

 

after 12 weeks

138.4 ± 59.0

143.4 ± 56.8

0.737

 

Differencec

-9.0 ± 67.1

-4.9 ± 0.2

0.775

 

p valued

0.444

0.484

 

0.751

HbA1c

Baseline

5.7 ± 0.6

5.8 ± 0.5

0.638

 

after 12 weeks

5.8 ± 0.5

5.8 ± 0.6

0.976

 

Differencec

0.1 ± 0.1

0.0 ± 0.1

0.417

 

p valued

0.711

0.358

 

0.502

Insulin

Baseline

6.8 ± 4.8

7.0 ± 5.5

0.870

 

after 12 weeks

7.3 ± 8.0

5.3 ± 5.3

0.269

 

Differencec

0.5 ± 3.2

-1.7 ± 0.2

0.243

 

p valued

0.686

0.226

 

0.172

C-peptide

Baseline

2.2 ± 1.0

2.2 ± 1.0

0.839

 

after 12 weeks

2.2 ± 1.4

1.8 ± 0.7

0.104

 

Differencec

0.0 ± 0.4

-0.4 ± 0.3

0.074

0.025*

p valued

0.898

0.010*

  
  1. aCompared between groups: p-value by independent t-test
  2. bCompared between groups: p-value by ANCOVA (adjustment with baseline and calorie)
  3. cDifference between the values of baseline and after 12 weeks
  4. dCompared within groups: p-value by paired t-test
  5. *p < 0.05